To enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC4428 | Rinoxiab |
Natural inducer of apoptosis by significantly upregulating Bcl-2, mitigating expression of Bcl2 in HCT 15 cells and attenuating the apoptotic markers and cell cycle regulatory proteins
More description
|
|
| DCC4427 | R-imeglimin |
Novel antidiabetic agent, impairing glucose uptake by muscle tissue, excessing hepatic gluconeogenesis, and increasing beta-cell apoptosis
More description
|
|
| DCC4426 | Rilpivirine Hydrochloride |
HIV-1 reverse transcriptase inhibitor, also acting as an EC 2.7.7.49 (RNA-directed DNA polymerase) inhibitor
More description
|
|
| DCC4424 | Rifamycin Sv |
Natural antibiotic, inhibiting prokaryotic DNA-dependent RNA synthesis and protein synthesis; blocking RNA-polymerase transcription initiation, modulating ß2m aggregation
More description
|
|
| DCC4423 | Rifametane |
Antibiotic for tuberculosis (TB) treatment
More description
|
|
| DCC4422 | Ricasetron |
Selective antagonist of the serotonin 5-HT3 receptor
More description
|
|
| DCC4421 | Rhodblock 1a |
Potent inhibitor of the Rho pathway
More description
|
|
| DCC4420 | rhm-138 |
Selective sigma-2 ligand, inducing apoptosis in EMT-6 breast cancer cells
More description
|
|
| DCC4419 | Rhlr Antagonist E22 |
Quorum sensing modulator as a RhlR antagonist
More description
|
|
| DCC4418 | Rhlr Antagonist 30 |
Novel potent and selective RhlR antagonist, strongly inhibiting biofilm formation, and reducing production of virulence factors in P. aeruginosa
More description
|
|
| DCC4417 | Rhlr Agonist S4 |
Quorum sensing modulator as a RhlR agonist
More description
|
|
| DCC4416 | Rhizoxin |
Potent tubulin assembly and cancer cell growth inhibitor
More description
|
|
| DCC4415 | Rh-5849 |
Novel Insect growth regulator, as potential insecticide to control olive fruit fly (Bactrocera oleae Rossi)
More description
|
|
| DCC4414 | Rh02007 |
Novel inhibitor of the human papillomavirus (HPV) E6 oncoprotein
More description
|
|
| DCC4413 | rh01617 |
Potent inhibitor of Kv1.5 potassium channel
More description
|
|
| DCC4412 | Rgia-5524 |
Novel Potent and Stable Antagonist of the Human α9α10 Nicotinic Acetylcholine Receptor for the Treatment of Neuropathic Pain
More description
|
|
| DCC4411 | rgh-237 |
Orally active, selective dopamine D3 receptor partial agonist
More description
|
|
| DCC4410 | Rgd-ss-ca |
Novel peptide-drug conjugate, inducing significant tumor growth suppression with negligible toxicity
More description
|
|
| DCC4409 | Rgd-mimetic-1 |
Novel avß6 selective arginyl-glycinyl-aspartic acid (RGD)-mimetic, demonstrating to bind with extremely high affinity and selectivity for the alphavß6 integrin and having the potential as a clinical tool and therapeutic for investigating the role of avß6
More description
|
|
| DCC4408 | Rgb-286147 |
Potent, selective & ATP-competitive inhibitor of Cdks
More description
|
|
| DCC4407 | Rg7388-tco |
Highly Potent Clickable Probe for Cellular Imaging of MDM2 and Assessing Dynamic Responses to MDM2-p53 Inhibition
More description
|
|
| DCC4406 | Rg-102240 |
Gene switch ligand as a transcription inducer for use in induceable gene expression systems
More description
|
|
| DCC4405 | Rf470dl |
Novel fluorescent D-amino acid for labeling peptidoglycans (PG) in live bacteria
More description
|
|
| DCC4404 | Rf3286 |
Novel Highly Selective Neuropeptide FF1 Receptor Antagonist, Potently Preventing Opioid-Induced Hyperalgesia
More description
|
|
| DCC4403 | Rf04289 |
Novel TLR2 activator
More description
|
|
| DCC4402 | Reveromycins Inducer Br-1 |
Novel biomediator that induces reveromycins production at the wide range of concentrations without affecting cell growth
More description
|
|
| DCC4401 | Revamilast |
Novel phosphodiesterase IV (PDE4) inhibitor for the treatment of Asthma and Rheumatoid Arthritis
More description
|
|
| DCC4400 | Rev1/ubm2 Inhibitor |
Novel inhibitor of the REV1/UbPCNA interaction, directly binding to REV1 UBM2 and preventing DNA damage tolerance (DDT)
More description
|
|
| DCC4399 | Retro-2.1 |
Novel potent inhibitor of EBOV infection and entry
More description
|
|
| DCC4398 | Resveratrol-4’-sulfate |
Metabolite of Resveratrol
More description
|
|